Hyunmin Jang
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 05, 2020
Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies.
Journal: Frontiers in neurology
Published: February 29, 2020
Erratum to: High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: January 17, 2020
Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: October 02, 2019
Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: April 26, 2019
High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: February 14, 2019
Therapeutic Outcome of Alemtuzumab in Korean Patients with Multiple Sclerosis: 2-Year Follow-Up.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: November 05, 2018
Neutralizing Antibodies Against Interferon-Beta in Korean Patients with Multiple Sclerosis.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: September 19, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026